The global Phosphatidylserine Market is estimated to be valued at US$ 2.27 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Phosphatidylserine is a fatty substance that is naturally present in foods such as fish, meat, eggs, and some plants. It is used in dietary supplements and has possible benefits such as improved brain function and memory, especially in older adults. It may also help support a healthy mood and cognitive abilities.
Market key trends:
The rising demand for dietary supplements from nutraceuticals and functional food & beverage industry is a major trend driving the phosphatidylserine market. Phosphatidylserine is known to improve cognitive functions such as problem solving, decision making and memory retention. It also supports brain health and neural communication. Due to growing awareness about cognitive decline in aging population, more people are consuming supplements containing phosphatidylserine. The increasing consumer preference for plant-based and vegan phosphatidylserine supplements is another emerging trend in the market.
Strength: Phosphatidylserine has various health benefits such as improved brain health and memory which drives its demand. It is available in dietary supplement form for oral consumption.
Weakness: Limited clinical research data available on long term impact and effectiveness of phosphatidylserine supplementation. High costs associated with its extraction process.
Opportunity: Growing geriatric population worldwide prone to age-related cognitive decline indicates potential for market growth. New product launches in form of gummies and softgels to attract newer consumer base.
Threats: Strict regulations associated with supplements industry. Competition from alternative brain health supporting ingredients.
Global Phosphatidylserine Market Size is expected to witness high growth, exhibiting CAGR of 6.3% over the forecast period, due to increasing health awareness among consumers regarding brain health supplements and rise in cognitive disorders.
Regional analysis: North America dominated the market in 2023 and is expected to continue its dominance over the forecast period. This is attributed to rising geriatric population and increasing cases of age-related cognitive disorders. Asia Pacific is expected to exhibit fastest growth rate during the forecast period due to growth in middle class population and improved spending on healthcare and wellness products.
Key players operating in the Phosphatidylserine market are Solgar Inc., Nature’s Way Products Llc., Wuhan Demekai biotechnology Co. ltd., Jarrow Formulas Inc, Lipoid Gmbh, Lipogen Products Ltd., Double Wood Llc., Xi€TMan Sino Herb Bio-Technology Co. Ltd., Xian Natural Field Bio- Technique Co. Ltd., N J Chsoyue Pharm Co. Ltd., Swanson Health Products Inc., ECA Healthcare Inc., and IvoVital Gmbh.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it